Pricing - HEOR - Access

Pricing - HEOR - Access

Our market access related courses aim to accelerate your learning curve in disciplines that are critical in the process of optimising market access, and even patient access.

Get up to speed in no time with CELforPharma’s 1- & 2-day courses by international industry experts in:

➙  Market Access in Europe       
➙  Market Access in the US       
➙  Value Pricing       
➙  Real World Evidence       
➙  Health Economics       
➙  Value-based Healthcare       
➙  Health Technology Assessment

Market Access in Europe

Understanding Pharma Market Access & Payers in Europe


By Dr. Nick Proctor


In this 1-day course, you will learn:

  1. The patterns in pricing & reimbursement systems and processes in France, Germany, Italy, Spain and the UK.

  2. Payer archetypes and the drivers of their decision-making processes

  3. The market access plan and process, and the contributions of internal stakeholders across functions.

  4. ...

Read More >

Dr. Nick Proctor

Market Access in the US

Understanding Pharma Market Access in the US


By Dr. Nick Proctor & Louisa Oliver 


In this 1-day course, you will learn:

  1. The structure and key players of US Managed Care systems, and how they compare with other global systems.

  2. The scope of medical benefit and how to navigate the pricing and access control mechanisms in this system.

  3. The role and significance of Pharmacy Benefit Managers (PBMs) and how to navigate the pricing and access control mechanisms in the pharmacy benefit system.

  4. ...

Read More >

Dr. Nick Proctor & Louisa Oliver

Value Pricing

How to Price Better Than Your Competitors for Successful Market Access

Essential Insights, Principles & Techniques


 By Gary Johnson & Sam Johnson


In this 2-day course, you will learn:

  1. An overview of payer types and of national pricing & market access systems around the world.

  2. The concepts and language of pharma pricing and market access that confuse many executives.

  3. Evidence-based research techniques for getting the most accurate feedback from payers about your product’s profile.

  4. ...

READ More >

Gary Johnson & Sam Johnson

Real World Evidence

Generating RWE for Optimising Market/Patient Access


By Prof. Dr. Thomas Wilke


In this 1-day course, you will learn:

  1. The expectations of external stakeholders regarding RWE along the product lifecycle

  2. The fundamental concepts, methodologies and research techniques of RWE in the context of optimising Market Access

  3. Critical success factors of a RWE study

  4. ...

READ More >

Prof. Dr. Thomas Wilke

Health Economics

Learn the Fundamentals of Health Economics

By Prof. Dr. Lieven Annemans


  1. The logic and math behind QALYs, ICERs, decision-trees and Markov models.

  2. How external stakeholders use and challenge health economic evidence.

  3. Key principles of cost-effectiveness analysis and Budget Impact Analysis.

  4. ...  


During a 2-day Face-to-Face Course:

Health Economics for Non-Health-Economists

READ More >




In an Online Self-Study Programme:

Basics of Health Economics

READ More >

Prof. Dr. Lieven Annemans

Value-based Healthcare

Value-based Healthcare for Pharma: Why – When – How?


By Dr. Silvia Rohr & Mark Tolboom


In this 1-day course, you will learn:

  1. The basic principles of Value-Based Healthcare (VBHC).

  2. How to build the internal case for VBHC and to evaluate the situation in your own organisation.

  3. The process and tools for assessing internal and external VBHC readiness and determining preparatory steps.

  4. ...

READ More >

Dr. Silvia Rohr & Mark Tolboom

Health Technology Assessment

Critical New HTA Developments in Europe: Challenges & Solutions


By Prof. Dr. Lieven Annemans 


In this 1-day course, you will learn:

  1. The different types of HTAs in Europe.

  2. How to address the broad and evolving array of assessment criteria in Europe.

  3. How to optimise clinical evidence generation for HTA bodies.

  4. How to use Real World Data for HTA purposes.

  5. How to prepare for the new Joint Clinical Assessment (JCA) in the EU.

READ More >

Prof. Dr. Lieven Annemans

Are you ready to take your career in the pharmaceutical industry to the next level? 

Discover CELforPharma's complete course portfolio, including topics you work on in cross-functional teams:

Course Finder